[{"Assets_0_Q3_USD":3214818000.0,"CommonStockSharesOutstanding_0_Q3_shares":215373548.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":579038000.0,"NetIncomeLoss_1_Q3_USD":128271000.0,"NetIncomeLoss_3_Q3_USD":335901000.0,"StockholdersEquity_0_Q3_USD":2422527000.0,"EarningsPerShareBasic_1_Q3_USD":0.6,"EarningsPerShareBasic_3_Q3_USD":1.57,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":215199000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":214628000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20191030"}]